Dr. Alluri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8525Fax+1 214-645-8527
Summary
- Dr. Alluri’s clinical focus is in treatment of breast cancer with radiation therapy. He sees the entire spectrum of breast cancer patients – from newly diagnosed early stage breast cancer patients seeking curative treatments to metastatic breast cancer patients looking for innovative clinical trials or palliative treatments for symptom relief.
Dr. Alluri also directs a research laboratory that's focused on understanding the molecular mechanisms of treatment resistance in breast cancer.
Education & Training
- University of MichiganResidency, Radiation Oncology, 2014 - 2017
- University of Michigan Health SystemFellowship, Translational Oncology, 2012 - 2014
- University of MichiganResidency, Surgery, 2009 - 2012
- University of Minnesota Medical SchoolClass of 2009
- University of Texas Southwestern Medical SchoolPh.D., Biological Chemistry, 2006
- Panjab UniversityMSc, Medicinal Chemistry, 1998
- Mangalore UniversityB.S., Pharmaceutical Sciences, 1996
Certifications & Licensure
- TX State Medical License 2017 - 2025
- MI State Medical License 2009 - 2019
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Breast Cancer Translational Research Award METAvivor, 2023
- Top Doctor in Radiation Oncology Castle Connolly, 2022-2023
- Breast Cancer - Bone Initiative Research Award Charles Pak Family Foundation, 2022
- Join now to see all
Clinical Trials
- Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity Start of enrollment: 2019 Dec 17
Publications & Presentations
PubMed
- 94 citationsBasal-like and triple-negative breast cancers: searching for positives among many negatives.Prasanna G. Alluri, Lisa A. Newman
Surgical Oncology Clinics of North America. 2014-07-01 - 7 citationsOn the feasibility of improved target coverage without compromising organs at risk using online adaptive stereotactic partial breast irradiation (A-SPBI).Steven K Montalvo, Nathan Kim, Chika Nwachukwu, Prasanna Alluri, David Parsons
Journal of Applied Clinical Medical Physics. 2023-02-01 - 39 citationsMetabolic diversity within breast cancer brain-tropic cells determines metastatic fitness.Pravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya Nair, Akash K Kaushik, Kangsan Kim
Cell Metabolism. 2022-01-04
Journal Articles
- "Androgen Receptor (AR) as a mediator and biomarker of radioresistance in triple-negative breast cancer"Speers, C., Zhao, S.G., Chandler, B., Liu, M., Wilder-Romans, K., Olsen, E., Nyati, S., Ritter, C., Alluri, P.G., Kothari, V., Hayes, D.H., Lawrence, T.S., Spratt, D.,..., NPG Breast Cancer, 1/1/2017
- "BETs Abet Tam-R in ER-Positive Breast Cancer"Alluri, P.G., Asangani, I.A., Chinnaiyan, A.M., Cell Res, 1/1/2014
- Basal-like and Triple Negative Breast Cancers: Searching for Positives Among Many NegativesAlluri, P.G., Newman, L.A., Surg Oncol Clin N Am, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- CDC20 is a therapeutic target in Triple Negative Breast CancerSharma, J., Nguyen, J., Raicu, I., Udden, S.M.N., Wang, Q., Alluri, P.G., San Antonio Breast Cancer Symposium, San Antonio, TX, 12/6/2018
- Targeting CDK4/6 inhibitor resistance in breast cancerWang, Q., Udden, S.M.N., Alluri, P.G., Conquer Cancer Foundation Scientific Retreat, Alexandria, VA, 10/10/2018
- Targeting Estrogen Receptor (ER) mutations for treatment of endocrine therapy resistance in breast cancerAlluri, P.G., Larios, J., Malik, R., Rae, J., Hayes, D., Speers, C., Chinnaiyan, A.M., ASTRO (American Society for Radiation Oncology) Annual Meeting, Boston, MA, 9/25/2016
- Join now to see all
Lectures
- Modeling treatment resistance in breast cancer: Advanced Center for Treatment, Research & Education in Cancer (ACTREC)Tata Memorial Center, Mumbai, India - 1/11/2019
- Targeting treatment resistance in breast cancer with BET inhibition.UT Southwestern Medical Center, Dallas, TX - 9/11/2018
- Bedside to bench approaches to model treatment resistance in breast cancer.Physician Scientist Conference, UT Southwestern Medical Center, Dallas, TX - 9/6/2018
- Join now to see all
Press Mentions
- METAvivor Announces Metastatic Breast Cancer Research AwardsJanuary 30th, 2023
- Drug Shows Promise in Overcoming Endocrine Therapy Resistance in Breast CancerNovember 15th, 2022
- Cary Council Recognizes UT Southwestern Doctors for Promising ResearchJanuary 2nd, 2019
- Join now to see all
Grant Support
- Metabolic imaging to study radiation-induced cardiac injuryUT Southwestern Department of Radiation Oncology2019–2020
- Targeting treatment resistance in breast cancerCary Council, Southwestern Medical Foundation2018–2019
- Targeting Estrogen Receptor mutations for treatment of endocrine therapy-resistant breast cancerConquer Councer Foundation/ Breast Cancer Research Foundation2017–2018
- Surgical Oncology Training GrantNational Cancer Institute2012–2014
- An integrated approach towards targeted therapies for prostate cancer and other epithelial cancersAmerican College of Surgeons2012–2013
- Role of Staf50 in HIV-1 pathogenesisAmerican Medical Association Foundation2006–2007
Committees
- Member, Resident Selection Committee, Department of Radiation Oncology, UT Southwestern Medical Center 2022 - Present
- Member, Diversity, Equity and Inclusion Committee, Department of Radiation Oncology, UT Southwestern Medical Center 2022 - Present
- Member, Clinical and Translational Research Committee, Department of Radiation Oncology, UT Southwestern Medical Center 2020 - Present
- Member, Breast Center Executive Committee, Harold Simmons Comprehensive Cancer Center 2019 - Present
- Member, Breast Program Leadership Committee, Committee, Harold Simmons Comprehensive Cancer Center 2019 - Present
- Member, UT Southwestern Medical School Admissions Committee 2018 - 2021
Professional Memberships
- Member
- Member
- Member
External Links
- Clinical Profile https://utswmed.org/doctors/prasanna-alluri/
- Faculty profile https://profiles.utsouthwestern.edu/profile/42027/prasanna-alluri.html
- Alluri Lab https://labs.utsouthwestern.edu/alluri-lab
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: